I am happy to share about the recent publication from one of our mega-trial:

• 举报此文章

Dr. Anup Choudhury, MD

Dr. Anup Choudhury, MD

Clinical Development Medical Director, Oncology-Hematology, Novartis Pharmaceuticals. Views expressed here are my own.

发布日期: 2024年10月23日

+ 关注

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

https://www.esmoopen.com/article/S2059-7029(24)01708-3/fulltext

要查看或添加评论，请登录

Dr. Anup Choudhury, MD的更多文章

• The seven types of rest that you need:

  2024年9月25日

  The seven types of rest that you need:

  The seven types of rest that people need are physical, mental, emotional, sensory, creative, social, and spiritual:…

  4

  2 条评论
• The 7 Habits of Highly Effective People

  2024年9月17日

  The 7 Habits of Highly Effective People

  “The 7 Habits of Highly Effective People” by Stephen R. Covey is a well-known self-help book that outlines seven key…

  6

  1 条评论
• Predictors of Successful Treatment-Free Remission with Tyrosine Kinase Inhibitors

  2024年9月16日

  Predictors of Successful Treatment-Free Remission with Tyrosine Kinase Inhibitors

  Successful treatment-free remission (TFR) in chronic myeloid leukemia (CML) patients treated with tyrosine kinase…

  7
• Treatment-Free Remission (TFR) in CML:

  2024年9月12日

  Treatment-Free Remission (TFR) in CML:

  Treatment-Free Remission (TFR) is a concept in the treatment of chronic myeloid leukemia (CML). Tyrosine kinase…

  11